EP0082712A2 — 2-Phenylimidazo(2,1-b)benzothiazole compounds, salts thereof, process for producing them, and pharmaceutical compositions containing them
Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1983-06-29 · 43y expired
What this patent protects
Novel 2-phenylimidazo[2,1-b]benzothiazole compounds shown by general formula I TAKE IN and the salts thereof, a process of producing the compounds, and pharmaceutical compositions containing the compounds. The compounds of this invention act on immune response, in part…
USPTO Abstract
Novel 2-phenylimidazo[2,1-b]benzothiazole compounds shown by general formula I TAKE IN and the salts thereof, a process of producing the compounds, and pharmaceutical compositions containing the compounds. The compounds of this invention act on immune response, in particular, suppress delayed type hypersensitivity reaction, and are useful as antiallergic agents, antirheumatics, therapeutic agents for autoimmune diseases, and suppressants of rejection after tissue transplantation and skin graft.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.